<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Initial management of T cell prolymphocytic leukemia</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Initial management of T cell prolymphocytic leukemia</h1>
<div class="graphic"><div class="figure"><div class="ttl">Initial management of T cell prolymphocytic leukemia</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">T cell prolymphocytic leukemia (T-PLL) is a rare, clinically aggressive T cell neoplasm composed of lymphoid cells, typically with involvement of the peripheral blood, bone marrow, lymph nodes, and spleen. Data regarding the treatment of T-PLL primarily come from retrospective analyses and small prospective trials. Given the uncertainties regarding treatment, we encourage patients to participate in clinical trials, whenever possible.</div><div class="graphic_footnotes">T-PLL: T cell prolymphocytic leukemia; CR: complete remission; HCT: hematopoietic cell transplantation.<br/>* Treatment is indicated for patients with one or more markers of "active disease." The threshold for rapidly increasing lymphocytosis depends on baseline lymphocyte count and clinical picture. As an example, therapy may be appropriate for a patient with a baseline lymphocyte count over 30,000/microL with doubling of the lymphocyte count in &lt;6 months, or an increase of more than 50% within two months.<br/>¶ For patients who have a suboptimal response to single-agent alemtuzumab, we suggest the addition of pentostatin. This includes patients progressing at any time; those who have stable disease after 4 to 6 weeks; and those with a response less than CR after 10 to 12 weeks.<br/>Δ Patients with no improvement or progression after four to six weeks should be referred for clinical trials.<br/><font class="lozenge">◊</font> Without HCT, remissions are short-lived. Allogeneic and autologous HCT appear to produce similar survival rates but differ in treatment-related mortality (TRM) and relapse rates. In general, we prefer allogeneic HCT for younger adults with a good performance status. An autologous HCT may be considered for patients who achieve a CR but are not candidates for an allogeneic HCT, because of age, fitness, or lack of a suitable donor.</div><div id="graphicVersion">Graphic 123116 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
